tiprankstipranks
Trending News
More News >
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market

Agios Pharma (AGIO) Technical Analysis

Compare
618 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Agios Pharma’s (AGIO) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Agios Pharma is a Sell.
Agios Pharma’s (AGIO) 20-Day exponential moving average is 28.79, while Agios Pharma’s (AGIO) share price is $30.17, making it a Buy.
Agios Pharma’s (AGIO) 50-Day exponential moving average is 29.75, while Agios Pharma’s (AGIO) share price is $30.17, making it a Buy.

Agios Pharma (AGIO) Pivot Points

May 22, 2025, 01:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.61
27.95
28.57
28.91
29.53
29.87
30.49
Fibonacci
27.95
28.32
28.55
28.91
29.28
29.51
29.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (AGIO) Moving Averages

May 22, 2025, 01:17 AM
Period
Simple
Exponential
MA5
28.81Buy
29.04Buy
MA10
28.51Buy
28.86Buy
MA20
28.98Buy
28.79Buy
MA50
29.12Buy
29.75Buy
MA100
31.49Sell
32.60Sell
MA200
39.26Sell
37.56Sell
Agios Pharma’s (AGIO) 10-Day exponential moving average is 28.86, while Agios Pharma’s (AGIO) share price is $30.17, making it a Buy.
Agios Pharma’s (AGIO) 100-Day exponential moving average is 32.60, while Agios Pharma’s (AGIO) share price is $30.17, making it a Sell.
Agios Pharma’s (AGIO) stock price is $30.17 and Agios Pharma’s (AGIO) 50-day simple moving average is 29.12, creating a Buy signal.
Agios Pharma’s (AGIO) stock price is $30.17 and Agios Pharma’s (AGIO) 100-day simple moving average is 31.49, creating a Sell signal.
Agios Pharma’s (AGIO) stock price is $30.17 and Agios Pharma’s (AGIO) 200-day simple moving average is 39.26, creating a Sell signal.

Agios Pharma (AGIO) Technical Indicators

May 22, 2025, 01:17 AM
Name
Value
Implied Action
RSI (14)
55.22
Neutral
STOCH (9,6)
64.86
Neutral
STOCHRSI (14)
43.72
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
17.19
Buy
Williams %R
-39.18
Buy
CCI (14)
65.07
Neutral
ATR (14)
1.43
-
Ultimate Oscillator
55.72
Neutral
ROC
2.54
Buy
Agios Pharma’s (AGIO) Relative Strength Index (RSI) is 55.22, creating a Neutral signal.
Agios Pharma’s (AGIO) Trend Strength Indicator (ADX) is 17.19, creating a Buy signal.
Agios Pharma’s (AGIO) Commodity Channel Index (CCI) is 65.07, creating a Neutral signal.
Agios Pharma’s (AGIO) Price Rate of Change (ROC) is 2.54, creating a Buy signal.

FAQ

Is AGIO a Buy, Hold, or Sell?
Based on AGIO’s technical indicators, AGIO is a Buy.
    What is AGIO’s RSI (14)?
    AGIO’s RSI (14) is 55.22, which suggests AGIO is a Neutral.
      What is AGIO’s MACD?
      AGIO’s MACD is -0.02, which suggests AGIO is a Sell.
        What is AGIO’s 5-day moving average?
        AGIO’s 5-day moving average is 28.81, which suggests AGIO is a Buy.
          What is AGIO’s 20-day moving average?
          AGIO 20-day moving average is 28.98, which suggests AGIO is a Buy.
            What is AGIO’s 50-day moving average?
            AGIO’s 50-day moving average is 29.12, which suggests AGIO is a Buy.
              What is AGIO’s 200-day moving average?
              AGIO’s 200-day moving average is 39.26, which suggests AGIO is a Sell.
                What is AGIO’s Williams % R (14)?
                AGIO’s Williams % R (14) is -39.18, which suggests AGIO is a Buy.
                  What is AGIO’s CCI (14)?
                  AGIO’s CCI (14) is 65.07, which suggests AGIO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis